<p><strong>联合健康集团</strong> UNH 面临新的法律压力，股东们提起了额外的诉讼，其中许多诉讼提到《华尔街日报》在五月报道的对公司医疗保险账单做法的联邦调查。</p>
<h2><strong>最新诉讼的细节</strong></h2>
<p><strong>史蒂夫·西尔弗曼</strong>，自 2003 年以来的联合健康股东，上周在明尼苏达州的联邦法院提起了一项派生诉讼。在派生诉讼中，股东代表公司对其领导层提出索赔，指控对公司本身造成损害。</p>
<p>西尔弗曼的投诉指控联合健康的领导层，包括首席执行官 <strong>斯蒂芬·赫姆斯利</strong>、前首席执行官 <strong>安德鲁·维蒂</strong> 及几位董事会成员，存在以下行为：</p>
<ul>
<li>违反受托责任</li>
<li>从事内幕交易</li>
<li>不当得利</li>
<li>违反 1934 年证券交易法</li>
</ul>
<p>该诉讼提到多篇关于联合健康账单做法的媒体报道，这些报道最终导致《华尔街日报》的一篇文章揭示司法部正在准备对该保险公司的医疗保险业务进行刑事调查。</p>
<p>&#34;尽管多次警告，联合健康对虚高编码做法的依赖至少持续到 2023 年，并显然延续到 2024 年，&#34;西尔弗曼的诉讼称，依据保险新闻网的报道。</p>
<p>&#34;这些策略带来了数十亿美元的过度报销，这一金额如此之大，以至于极大地夸大了公司的财务业绩和股价，&#34;诉讼中指控称。</p>
<p>联合健康尚未对该诉讼发表评论。针对《华尔街日报》的报道，该公司表示尚未收到任何司法部调查的通知，并为其医疗保险优势计划的完整性辩护。</p>
<h2><strong>其他股东行动</strong></h2>
<p>其他投资者也提起了类似的诉讼：</p>
<ul>
<li>约瑟夫·克罗格纳尔于 6 月 30 日提起投诉，指名与西尔弗曼相同的 14 名被告。</li>
<li>梅里·科古特于 6 月 14 日提起派生诉讼，指控联合健康的领导层未能披露 2023 年底的劳动部调查。科古特声称，在此期间，公司以虚高价格回购了 73 亿美元的股票，而高管们在司法部调查仍然保密时从股票销售中获利。</li>
</ul>
<p>科古特的诉讼指控赫姆斯利在司法部调查公开前从股票销售中获利 2.115 亿美元，维蒂获利 1100 万美元。</p>
<p>这三起诉讼都集中在联合健康的医疗保险账单和报告做法上。原告认为，尽管公司的医疗保险业务非常盈利，但也吸引了负面关注，损害了其股价。</p>
<h2><strong>联合健康动荡不安</strong></h2>
<p>联合健康目前面临一系列挑战，包括这些诉讼、司法部调查、特朗普政府的监管变化以及最近的领导层动荡。</p>
<p>联合健康首席执行官安德鲁·维蒂于五月辞职，公司在发布之前的盈利预测不到一个月后撤回了该预测。</p>
<p>此外，《华尔街日报》在周三发布了一份新报告，称前联合健康员工告诉司法部调查人员，该公司在患者评估期间鼓励捕捉某些有利可图的诊断。</p>
<p>联合健康集团定于 7 月 29 日公布其第二季度财报和更新的指导意见。</p>
<p>根据 Benzinga Pro 的数据，UNH 股票年初至今已下跌超过 40%，在周三发布时交易价格为 302.10 美元。</p>
<ul>
<li><strong>SoFi 准备在特朗普的 ‘大、美丽’ 计划限制联邦学生贷款时 ‘抓住机会’</strong></li>
</ul>
<p><em>照片：Shutterstock</em></p>

联合健康

<p>联合健康集团（UnitedHealth Group, Inc.）正面临新的法律挑战，因为股东们针对其医疗保险账单做法提起了多起诉讼，这与联邦调查有关。股东史蒂夫·西尔弗曼（Steve Silverman）提起的派生诉讼指控公司领导层违反信托责任和内幕交易，声称夸大的编码做法导致了过高的报销和显著的股价膨胀。其他投资者也提起了类似的诉讼，强调对未披露调查和以高价回购股票的担忧。在这些争议和领导层变动的背景下，联合健康的股票今年已暴跌超过 40%</p>

<p><strong>UnitedHealth Group, Inc.</strong> UNH is under renewed legal pressure as shareholders file additional lawsuits, many of which reference a federal investigation into the company's Medicare billing practices reported by the Wall Street Journal in May.</p>
<div class="lb-trans"><p><strong>联合健康集团</strong> UNH 面临新的法律压力，股东们提起了额外的诉讼，其中许多诉讼提到《华尔街日报》在五月报道的对公司医疗保险账单做法的联邦调查。</p>
</div><h2><strong>Details of the Latest Lawsuit</strong></h2>
<div class="lb-trans"><h2><strong>最新诉讼的细节</strong></h2>
</div><p><strong>Steve Silverman</strong>, a UnitedHealth shareholder since 2003, filed a derivative lawsuit last week in federal court in Minnesota. In a derivative suit, a shareholder brings claims on behalf of the company against its own leadership, alleging harm to the corporation itself.</p>
<div class="lb-trans"><p><strong>史蒂夫·西尔弗曼</strong>，自 2003 年以来的联合健康股东，上周在明尼苏达州的联邦法院提起了一项派生诉讼。在派生诉讼中，股东代表公司对其领导层提出索赔，指控对公司本身造成损害。</p>
</div><p>Silverman's complaint accuses UnitedHealth's leadership, including CEO <strong>Stephen Hemsley,</strong> former CEO <strong>Andrew Witty</strong> and several board members, of:</p>
<div class="lb-trans"><p>西尔弗曼的投诉指控联合健康的领导层，包括首席执行官 <strong>斯蒂芬·赫姆斯利</strong>、前首席执行官 <strong>安德鲁·维蒂</strong> 及几位董事会成员，存在以下行为：</p>
</div><ul>
<li>Breaching their fiduciary duties</li>
<li>Engaging in insider trading</li>
<li>Unjust enrichment</li>
<li>Violating the Securities Exchange Act of 1934</li>
</ul>
<div class="lb-trans"><ul>
<li>违反受托责任</li>
<li>从事内幕交易</li>
<li>不当得利</li>
<li>违反 1934 年证券交易法</li>
</ul>
</div><p>The lawsuit references multiple media reports about UnitedHealth's billing practices, which culminated in the Wall Street Journal article that revealed the Department of Justice was preparing a criminal probe into the insurer's Medicare operations.</p>
<div class="lb-trans"><p>该诉讼提到多篇关于联合健康账单做法的媒体报道，这些报道最终导致《华尔街日报》的一篇文章揭示司法部正在准备对该保险公司的医疗保险业务进行刑事调查。</p>
</div><p>&#34;Despite repeated warnings, UnitedHealth's reliance on inflated coding practices continued through at least 2023 and apparently into 2024,&#34; Silverman's lawsuit claimed, according to Insurance Newsnet.</p>
<div class="lb-trans"><p>&#34;尽管多次警告，联合健康对虚高编码做法的依赖至少持续到 2023 年，并显然延续到 2024 年，&#34;西尔弗曼的诉讼称，依据保险新闻网的报道。</p>
</div><p>&#34;These tactics yielded billions of dollars in excessive reimbursements, a sum so large that it vastly inflated the Company's financial results and stock price,&#34; the lawsuit alleges.</p>
<div class="lb-trans"><p>&#34;这些策略带来了数十亿美元的过度报销，这一金额如此之大，以至于极大地夸大了公司的财务业绩和股价，&#34;诉讼中指控称。</p>
</div><p>UnitedHealth has not commented on the lawsuit. In response to the Wall Street Journal's reporting, the company stated it had not been notified of any DOJ investigation and defended the integrity of its Medicare Advantage program.</p>
<div class="lb-trans"><p>联合健康尚未对该诉讼发表评论。针对《华尔街日报》的报道，该公司表示尚未收到任何司法部调查的通知，并为其医疗保险优势计划的完整性辩护。</p>
</div><h2><strong>Additional Shareholder Actions</strong></h2>
<div class="lb-trans"><h2><strong>其他股东行动</strong></h2>
</div><p>Other investors have filed similar lawsuits:</p>
<div class="lb-trans"><p>其他投资者也提起了类似的诉讼：</p>
</div><ul>
<li>Joseph Crognale filed a complaint on June 30, naming the same 14 defendants as Silverman.</li>
<li>Merry Kogut filed a derivative suit on June 14, alleging that UnitedHealth's leadership failed to disclose a Department of Labor investigation in late 2023. Kogut claims the company repurchased $7.3 billion in stock at inflated prices during this period, and that executives profited from share sales while the DOJ probe was still secret.</li>
</ul>
<div class="lb-trans"><ul>
<li>约瑟夫·克罗格纳尔于 6 月 30 日提起投诉，指名与西尔弗曼相同的 14 名被告。</li>
<li>梅里·科古特于 6 月 14 日提起派生诉讼，指控联合健康的领导层未能披露 2023 年底的劳动部调查。科古特声称，在此期间，公司以虚高价格回购了 73 亿美元的股票，而高管们在司法部调查仍然保密时从股票销售中获利。</li>
</ul>
</div><p>Kogut's lawsuit alleges that Hemsley made $211.5 million and Witty $11 million from stock sales before the DOJ investigation became public knowledge.</p>
<div class="lb-trans"><p>科古特的诉讼指控赫姆斯利在司法部调查公开前从股票销售中获利 2.115 亿美元，维蒂获利 1100 万美元。</p>
</div><p>All three lawsuits center on UnitedHealth's Medicare billing and reporting practices. Plaintiffs argue that while the company's Medicare business has been highly profitable, it has also attracted negative attention that has hurt its stock price.</p>
<div class="lb-trans"><p>这三起诉讼都集中在联合健康的医疗保险账单和报告做法上。原告认为，尽管公司的医疗保险业务非常盈利，但也吸引了负面关注，损害了其股价。</p>
</div><h2><strong>UNH in Turmoil</strong></h2>
<div class="lb-trans"><h2><strong>联合健康动荡不安</strong></h2>
</div><p>UnitedHealth is currently facing a series of challenges, including these lawsuits, a DOJ investigation, regulatory changes from the Trump administration and recent leadership upheaval.</p>
<div class="lb-trans"><p>联合健康目前面临一系列挑战，包括这些诉讼、司法部调查、特朗普政府的监管变化以及最近的领导层动荡。</p>
</div><p>UnitedHealth CEO Andrew Witty resigned in May, and the company withdrew its previous earnings forecast less than a month after issuing it.</p>
<div class="lb-trans"><p>联合健康首席执行官安德鲁·维蒂于五月辞职，公司在发布之前的盈利预测不到一个月后撤回了该预测。</p>
</div><p>Additionally, the Wall Street Journal released a new report on Wednesday, which claims that former UnitedHealth employees told DOJ investigators that the company encouraged the capture of certain lucrative diagnoses during patient assessments.</p>
<div class="lb-trans"><p>此外，《华尔街日报》在周三发布了一份新报告，称前联合健康员工告诉司法部调查人员，该公司在患者评估期间鼓励捕捉某些有利可图的诊断。</p>
</div><p>UnitedHealth Group is set to report its second-quarter earnings and updated guidance on July 29.</p>
<div class="lb-trans"><p>联合健康集团定于 7 月 29 日公布其第二季度财报和更新的指导意见。</p>
</div><p>UNH shares have fallen more than 40% year-to-date, according to Benzinga Pro, and were trading at $302.10 at the time of publication on Wednesday.</p>
<div class="lb-trans"><p>根据 Benzinga Pro 的数据，UNH 股票年初至今已下跌超过 40%，在周三发布时交易价格为 302.10 美元。</p>
</div><ul>
<li><strong>SoFi Ready To ‘Capture The Opportunity’ As Trump’s ‘Big, Beautiful’ Plan Restricts Federal Student Loans</strong></li>
</ul>
<div class="lb-trans"><ul>
<li><strong>SoFi 准备在特朗普的 ‘大、美丽’ 计划限制联邦学生贷款时 ‘抓住机会’</strong></li>
</ul>
</div><p><em>Photo: Shutterstock</em></p>
<div class="lb-trans"><p><em>照片：Shutterstock</em></p>
</div>

联合健康因股票暴跌 1190 亿美元再次面临诉讼